Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

This billing and coding article (A58865) provides guidance for amniotic- and placental-derived product injections/applications for musculoskeletal, non-wound indications and refers to Local Coverage Determination L39116 for substantive coverage rules. The article itself does not list specific indications, limitations, documentation requirements, or frequency limits; those details must be obtained from LCD L39116 and reviewed for claim adjudication.

"No specific clinical indications are provided in this billing and coding article; coverage criteria for amniotic and placental-derived product injections/applications for musculoskeletal non-wound ..."

Sign up to see full coverage criteria, indications, and limitations.